Op-Ed: Sanofi CEO on navigating Covid one year later. Now what?
Paul Hudson is the CEO of Sanofi. The French pharmaceutical company has two Covid-19 vaccines under development — one with GlaxoSmithKline, the other with Translate Bio for an mRNA vaccine. It's also manufacturing vaccine doses for competitors Johnson & Johnson and Pfizer. As we enter the one-year anniversary of initial lockdowns across the globe, it is clear the Covid-19 pandemic […]
Read more